Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy

Summary

The goal of this clinical trial is to determine if utilizing the Quest AD-Detect blood test, while patient's are hospitalized for a cognitive diagnosis (such as delirium or encephalopathy), will result in an earlier diagnosis of underlying Alzheimer's disease. * Will this blood test have the ability to distinguish between Alzheimer's disease and other causes of cognitive impairment in the inpatient setting? * Neurology Clinic will complete a 6-month post-hospitalization follow up with patients who have had the Quest AD-Detect Alzheimer's Disease blood test completed while they were inpatient to discuss the risk assessment portfolio

Interventions

• Quest AD-Detect blood test · DIAGNOSTIC_TEST

  Blood will be collected and sent for testing using the Quest AD-Detect blood test

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria:

* Ages 60 to 90 years old
* No prior diagnosis of dementia
* Currently hospitalized with cognitive diagnosis, including but no limited to; delirium, encephalopathy, etc. thought to be secondary to a toxic/metabolic state

Exclusion Criteria:

* Age under 60 years
* Prior diagnosis of dementing illness or other organic etiology to cognitive impairment

Sites (6)

• Cumberland Medical Center, Crossville, Tennessee · RECRUITING
• Roane Medical Center, Harriman, Tennessee · RECRUITING
• Fort Sanders Regional Medical Center, Knoxville, Tennessee · RECRUITING
• Fort Loudon Medical Center, Lenoir City, Tennessee · RECRUITING
• Methodist Medical Center, Oak Ridge, Tennessee · RECRUITING
• LeConte Medical Center, Sevierville, Tennessee · RECRUITING